Abstract:
The present invention provides a method of producing a rabies glycoprotein G by culturing cells of a methylotrophic species of yeast, which have a gene capable of expressing the pre-form of the rabies glycoprotein G in such cells, under conditions such that the gene is transcribed. The preferred species of yeast for carrying out the invention is Pichia pastoris. Mature rabies glycoprotein G is expressed at a high level in methylotrophic yeast cells as an extractable, membrane-associated glycoprotein. Also provided by the invention are DNAs capable of transforming methylotrophic yeast to express rabies pre-glycoprotein Gs, cultures of cells of such a yeast transformed with such DNAs and the novel glycosylated rabies glycoprotein Gs made by the method of the invention. The rabies glycoprotein G provided by the invention is useful as an immunogen in vaccines to protect mammals against infection by rabies virus.